Pediatric Crohn's Disease
Also known as: Pediatric Crohn’s Disease / Pediatric Crohns Disease
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00065 | Infliximab | A monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00065 | Infliximab | Tumor necrosis factor | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00051 | Adalimumab | 1 | Completed | 1 |
| DB17743 | Fecal microbiota | 1 | Completed | 1 |
| DB17743 | Fecal microbiota | 1 / 2 | Completed | 1 |
| DB00207 | Azithromycin | 2 | Recruiting | 1 |
| DB00916 | Metronidazole | 2 | Recruiting | 1 |
| DB00065 | Infliximab | 3 | Completed | 1 |
| DB00563 | Methotrexate | 3 | Completed | 1 |
| DB00993 | Azathioprine | 4 | Withdrawn | 1 |
| DB00065 | Infliximab | 4 | Withdrawn | 1 |
| DB00959 | Methylprednisolone | 4 | Withdrawn | 1 |
| DB00065 | Infliximab | Not Available | Unknown Status | 1 |